Kimyrsa Prices, Coupons and Patient Assistance Programs
Kimyrsa is available as a brand name drug only, a generic version is not yet available. See generic Kimyrsa availability.
Kimyrsa (oritavancin) is a member of the glycopeptide antibiotics drug class and is commonly used for Skin and Structure Infection.
The cost for Kimyrsa intravenous powder for injection 1200 mg is around $5,152 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Kimyrsa price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Powder For Injection
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Kimyrsa Coupons and Rebates
Kimyrsa offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Kimyrsa Copay Savings Program: Eligible commercially insured patients may pay as little $50 per treatment; program will cover up to $1,000 of a patient
- Applies to:
- Number of uses:
- Per prescription until program expires
Form more information phone: 844-546-9772 or Visit website
Patient Assistance Programs for Kimyrsa
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Kimyrsa Support ProgramsElligibility requirements:
- Determined case by case
- Based on FPL
- Medically appropriate condition/diagnosis
- The patient must be a US citizen or legal resident.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Kimyrsa (oritavancin) Injection; IV
More information please phone: 844-546-9772 Visit Website
More about Kimyrsa (oritavancin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- En español
- Drug class: glycopeptide antibiotics
- FDA approval history